Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,255 | -3,833 | -4,224 | -2,551 | -593 |
| Depreciation Amortization | 10 | 9 | 917 | 294 | 152 |
| Income taxes - deferred | N/A | N/A | N/A | 120 | N/A |
| Accounts receivable | -23 | 33 | -34 | 25 | 18 |
| Other Working Capital | 961 | 640 | 127 | 57 | -351 |
| Other Operating Activity | 119 | 89 | 262 | 66 | 142 |
| Operating Cash Flow | $-3,188 | $-3,063 | $-2,951 | $-1,989 | $-631 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -2 | 915 | -419 | -174 |
| Other Investing Activity | 36 | 34 | 28 | 0 | 0 |
| Investing Cash Flow | $33 | $32 | $943 | $-419 | $-174 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 55 | N/A |
| Debt Repayment | N/A | N/A | -754 | -95 | -57 |
| Common Stock Issued | 4,102 | 3,341 | 1,880 | 1,911 | 3,024 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -50 |
| Financing Cash Flow | $4,102 | $3,341 | $1,126 | $1,870 | $2,917 |
| Beginning Cash Position | 1,271 | 960 | 1,842 | 2,380 | 269 |
| End Cash Position | 2,217 | 1,271 | 960 | 1,842 | 2,380 |
| Net Cash Flow | $946 | $311 | $-882 | $-538 | $2,112 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,188 | -3,063 | -2,951 | -1,989 | -631 |
| Capital Expenditure | -3 | -7 | -9 | -419 | -174 |
| Free Cash Flow | -3,191 | -3,069 | -2,960 | -2,409 | -805 |